Skip to Content
Cancer Therapy Evaluation Program (CTEP)
Contact NExT
Show menu
Search this site
Last Updated: 10/13/21

Rabih Said, MD

Physician

Dr. Rabih Said earned his MD from Lebanese University, Beirut, Lebanon, in 2002. He is ECFMG certified. He finished his Internal Medicine Residency and Hematology/oncology fellowship training at Northwell Health Staten Island University hospital in New York, NY, in 2011. From 2011 to 2012, Dr. Said was at MD Anderson Cancer Center for a special fellowship training in the Investigational Cancer Therapeutics (ICT) department focusing on designing, writing, and conducting early drug development trials (phase 1 trials) for patients with advanced cancer. In 2012, Dr. Said joined the University of Texas Health Science Center as an assistant professor in the Medical Oncology Division and as visiting assistant professor at the ICT department at MD Anderson Cancer Center where he conducted several phase 1 trials as principal investigator and co-investigator. In 2016, Dr. Said moved to Lebanon and joined the prestigious St. George Hospital University Medical Center and the University of Balamand as an associate professor where he was appointed as hematology/oncology fellowship director. He was also a consultant on the Lebanese national medical oncology committee of the Lebanese Ministry of Public Health. Dr. Said is board certified in both hematology and medical oncology.

About the Branch Chief

Steven Gore, MD Steven Gore, MD, earned his undergraduate and doctoral degrees at Yale, performed his residency at the University of Chicago and his oncology fellowship at Johns Hopkins. He rose from instructor to full professor at Johns Hopkins, and, in 2013, he became professor of medicine and director of hematologic malignancies at Yale. He joined the Investigational Drug Branch at CTEP in 2020. More…